Abstract: Bone fractures may depend on Vitamin D Receptor Gene (VDR), bone mineral density, bone turnover markers. Patients and methods.
Introduction
Long bone fractures are a considerable problem in the developmental age population. Current literature shows a prevalence exceeding 40% of boys and approximately 27% of girls before the age of 16 years. The greatest incidence of fractures in the developmental age is noted in both sexes at slightly varying ages: 11-12 years in girls, and 13-14 years in boys [1] [2] [3] . Increased prevalence of fractures in boys has been shown in numerous populations, and is thought to be related to a greater injury rate due to risky activities [1, 3, 4] . Reduced mineral bone density -BMD, plays a crucial role in the aetiology of fractures, not limited to the developmental age group [1, [3] [4] [5] . BMD depends on both environmental and genetic factors. Environmental ones include: low calcium intake, vitamin D deficiency, reduced physical activity and chronic diseases necessitating treatment with glucocorticosteroids [4] [5] [6] . Genetic factors include variability of bone turnover-regulating genes [6] . The vitamin D receptor gene (VDR) is one such example. Therefore, the aim of this study was to analyse selected factors related to fractures, such as the relationship between VDR polymorphism and the incidence of bone fractures in pediatric patients.
Materials and methods
The study group consisted of 161 patients of Department of Paediatric Propedeutics and Bone Metabolism Diseases aged 6-18 years old. All patients underwent genotyping using restriction enzyme length polymorphism (RFLP) method within polymorphic loci BsmI (rs1544410), FokI (rs2228570), ApaI (rs7975232) and TaqI (rs731236), of the VDR gene. All paediatric subjects underwent skeletal densitometry examination using dual energy X-ray absorption measurements (DXA), on a Lunar Prodigy Advance device (GE Healthcare, Madison, USA), with paediatric settings. Two programmes were used: Total body and L2-L4 spine. The study time was 4 minutes for Total body, and 30 seconds for AP spine. Radiation doses equalled 0.37 μGy and 37 μGy, respectively. The measurement error for both programmes was below 1% (<1%CV). BMD (g/cm 2 , Z-score) and BMC (g, Z-score) values in both densitometry projections have been evaluated. Tests were performed at the Regional Centre for Menopause and Osteoporosis of the Clinical Hospital No 3 of the Medical University of Lodz. Low bone mass was diagnosed when Z-score in total body or spine programme >-1.0 [8, 9] . The result of bone densitometry examination was the eligibility criteria for genetic research in paediatric patients. In patients from data base of Immunopathology and Genetic Laboratory densitometric examination were not performed.
161 children and teenagers have been interviewed for fractures over the last two years too. Those past fractures were treated as main symptoms of low bone mass. After assessment, the patients were divided into two groups: without bone fractures (n=88) or with long bone or vertebral fractures (n=73 children). All fractures were low-energy fractures (without trauma, from a height of one's own body) and they were diagnosed by X-ray examination. In all children two biochemical parameters were made. Osteocalcin (OC, bone formation marker) in the serum and collagen type I cross-linked N-telopeptide (Ntx, marker of bone resorption) in urine were established by Elisa method. The values between 25 th and 75 th percentile for the same sex and age for bone turnover markers were taken as normal [10, 11] .
The studies were approved by the Local Bioethics Committee No RNN/72/05/KE (8.03.2005).
Molecular methods

BsmI polymorphism
For the purpose of identifying the BsmI polymorphism (rs1544410) located in the 8 th intron of the VDR gene, the authors have performed amplification of the region using oligonucleotide primers: 5' GCG ATT CGT AGG GGG GAT TCT G 3' and 5' TCT CCA TTC CTT GAG CCT CCA GTC C 3' which yielded a fragment of 403 base pairs. The PCR reaction was conducted in a volume of 20 mL: containing 0.1-0.5 mg of genomic DNA, 8 mM of dNTP, 2-3 mM of MgCl 2 , 2U of Taq DNA polymerase (TIB Molbiol, Poznan, Poland). Reaction conditions were established empirically: 10 minutes at 95o C of initial denaturation, 35 cycles of: denaturation -30 sec at 94°C, primer annealing 30 sec 60°C, elongation of DNA strands 30 sec in 72°C; final elongation 10 minutes in 72°C. Following that, 6 mL of amplified product was subjected to restriction enzyme BsmI (MBI Fermentas, Vilinus, Lithuania) digestion (0.2 U) at 37°C for 12 hours. The enzyme did not cleave the DNA strands if the A allele was present (the resulting fragment was 403 base pairs in length), and in case of the G allele cleavage at one site yielded products of 337 and 66 base pairs. The resulting products were separated using 2% agarose gel electrophoresis.
ApaI and TaqI polymorphisms
The PCR-RFLP method was also used for the purpose of detecting ApaI (rs11168271) and TaqI (rs731236) polymorphisms. The PCR reaction was conducted in a volume of 20 mL: containing 0.1-0.5 mg of genomic DNA, 8 mM of dNTP, 2-3 mM of MgCl 2 , 2U of Taq DNA polymerase (TIB Molbiol, Poznan, Poland). Reaction conditions were established empirically: 10 minutes at 95°C of initial denaturation, 35 cycles of: denaturation -30 sec at 94°C, primer annealing 45 sec 65°C, elongation of DNA strands 30 sec in 72°C; final elongation 10 minutes in 72°C. For this reaction primer pairs: 5' CAC GGA GAA GTC ACT GGA GGG C 3' and 5' TCA TCT TGG CAT AGA GCA GGT GG 3' were used and yielded a fragment of 307 base pairs. After applying the ApaI or TaqI restriction enzymes (0.2 U) (MBI Fermentas, Vilinus, Lithuania) onto 6 mL of PCR products and incubating in 37°C for 12 hours, the following digestions took place: if the C allele of the ApaI polymorphism was present, the enzyme cleaved DNA at one location (producing fragments of 175 and 132 base pairs of length), if the A allele was present, the ApaI enzyme did not cleave the DNA product. Presence of the T allele at the TaqI polymorphic site did not result in DNA cleavage, whereas the C allele produced one digestion site, splitting the product to fragments 212 and 95 base pair long. The resulting products were separated using 2% agarose gel electrophoresis.
FokI polymorphism
The amplification of a 258 base pair fragment including the FokI polymorphism (rs10735810) of the VDR gene was performed using PCR-RFLP using oligonucleotide primers: 5' CCC TGG CAC TGA CTC TGG CTC TG 3' and 5' GAA ACA CCT TGC TTC TTC TCC CTC C 3'. The PCR reaction was conducted in a volume of 20 mL: containing 0.1-0.5 mg of genomic DNA, 8 mM of dNTP, 2-3 mM of MgCl 2 , 2U of Taq DNA polymerase (TIB Molbiol, Poznan, Poland). Reaction conditions were established empirically: 10 minutes at 95°C of initial denaturation, 35 cycles of: denaturation -30 sec at 94°C, primer annealing 30 sec 60°C, elongation of DNA strands 30 sec in 72°C; final elongation 10 minutes in 72°C. Following that, 6 mL of amplified product was subjected to restriction enzyme FokI (MBI Fermentas, Vilinus, Lithuania) digestion (0.2 U) at 37°C for 12 hours. The FokI restriction enzyme cleaved the DNA product at one site into 194 and 64 base pair fragments if the T allele was present. If the C allele was present, the full product of 258 base pairs was not cleaved. The resulting products were separated using 2% agarose gel electrophoresis.
Statistical analysis
Logistic regression was applied to evaluate factors associated with bone fractures. Backward, stepwise variable selection was employed for multivariate analysis of factors significant in univariate comparisons. The model included parameters standardized for age and gender (Z-scores), bone metabolism markers' concentrations and polymorphic alleles data. The threshold for significance in the final model was p<0.05 corresponding to the 95% Confidence Interval (95%CI) for odds ratio (OR) not overlapping the value of 1. Subgroup analysis in patients with reduced bone mass did not include BMDt Z-score as it was one of the diagnostic criteria for subgroup selection.
Results
Among patients with a history of fractures, 242 incidents of long bone fracture and 40 vertebral fractures were recorded. The number of fractures per one child was between 1 and 30, and the number of vertebral fractures was between 1 and 8 (the vertebrae most frequently affected were L1 (5/40) and TH 7 and 8 (4/40). As shown on Figure 1 , repeated fractures were the most frequent to occur in children, with 24/73 patients suffering more than 3 fractures. In 21 out of 73 children, bone and vertebrae fractures were secondary to the underlying disease and its treatment (7/21 patients were diagnosed with osteogenesis imperfecta, 6 suffered from asthma, 5 suffered from acute lymphoblastic leukemia, and 3 -from Crohn's disease). In the remaining 52 children, fractures were not associated with any underlying disorders and were of primary nature.
Reduced mineral bone density (Z-score BMD below -1.1) was detected in 66/73 patients with bone fractures. Statistically significant differences between groups weren't noted. Tanner stage was marginally associated with risk of fractures (p=0,07), with prepubertal children having the lowest risk (13/41), those with Tanner stage 2-4 the highest (38/83) and those with a Tanner stage of 5 being in the middle (14/30). This was not confirmed in multivariate analysis (p>0.15) and the variable was excluded in the stepwise selection procedure, although this lack of effect could be linked to a small sample size. The effect of gender was similarly non-significant (p=0,40), although boys did have slightly more frequent fractures (47/95 vs 26/61). Table 1 contains mean densitometry Z-score values and bone turnover indexes in the group of children with and without fractures. Tables 2 and 3 show the relative effect of VDR genotypes at BsmI, TaqI ApaI and FokI polymorphic sites evaluated for all genotypes (Table 2 ) and polymorphic allele carriage (Table 3) .
Analysis of the entire study group (161 children) has shown that variables related to fracture occurrence was osteocalcin level and with a p value near significance -Z-score BMDt. OR values for various parameters were 1.01 (95% CI 1.00-1.02) for osteocalcin (p=0.006), and 0.66 (95% CI 0.42-1.03; p=0.07) for Z-score BMDt, respectively. This means that one BMDt standard deviation reduces the fracture risk by 41%, and an increase of osteocalcin level by 1 result in a 1% increased fracture risk.
Subgroup analysis in patients with reduced bone mass did not include BMDt Z-score as it was one of the diagnostic criteria for subgroup selection. Factors related to fracture incidence in these selected patients were: osteocalcin (0.04), BsmI b (0.07) and ApaI a (0.08) allele carriage. ORs equalled 1.01 (5% CI 1.00-1.02) for OC, 0.29 (95% CI 0.07-1.14) for BsmI b and 2.13 (95% CI 0.91-4.99) for ApaI a allele carriage respectively. Parameters of the final multivariate model in children with low bone mass are presented in Table 4 . The analysis showed that BsmI b allele had a protective effect, while the ApaI a allele was related to an increased risk of fracture occurrence in children with reduced bone mass. Osteocalcin, similarly to patients with normal bone mass, showed a negative effect, contributing to increased risk of fractures.
Discussion
Analysis of bone fracture reasons in the developmental age indicates the impact of factors such as age, sex, pubertal phase, reduced physical activity or presence of a chronic disease and its treatment [1] [2] [3] [4] [5] [6] 12] . In the evaluated group of children, fractures of bones and vertebrae in 21 children were diagnosed simultaneously with the chronic disease, while in 2 children fractures were one of multiple symptoms of idiopathic juvenile osteoporosis. Apart from clinical symptoms, skeletal densitometry was the basis for diagnosing idiopathic juvenile osteoporosis (Z-score below -2.1) [8, 9] . In children with OI medical history of bone fractures were made in the first hospitalisation in our Clinic. The correlation between reduced bone mass and risk of fractures was widely reported in numerous earlier studies [1, [3] [4] [5] . In children with recurrent fractures, Manias et al. have shown significantly reduced BMB and BMC values, in comparison with a control group [5] . Studies performed by Key et al. also showed reduced bone mass of various sections of the skeleton in 15 out of 16 children with bone fractures [13] . Among pre-pubertal girls with forearm fracture, potential risk factors of such fractures included significantly reduced BMD, low levels of physical activity and excessive weight [14] . Studies conducted by Goulding et al. in a group of girls aged 3-15 years, not only showed a role of reduced BMD, by also the fact that a previous forearm fracture may promote subsequent ones [15] . In our studies, 24/73 children suffered more than 3 bone fractures. However, spontaneous bone fractures in the developmental age (8-18 years), even multiple ones, do not necessarily contribute to increased risk of fractures occurring above the age of 50, a fact demonstrated by the EPOS studies [16] . In the presented paper, an increase in serum osteocalcin levels was also a factor increasing the risk of fractures. Our study group has already reported significantly accelerated bone turnover in children with repeated fractures [4, 17] . Levels of osteocalcin fragments excreted with urine are reported as a potential marker of bone fractures occurring in elderly women [18, 19] .
Osteocalcin concentration is measured within the serum or in the urine (in its degraded form), its levels reflect the intensity of bone turnover processes. This may depend on patients' age (growth period) or presence of previous fractures and healing process. Our analyses were based on age and sex-corrected parameters and all examinations were performed at least 6 months following the last fracture to exclude the possibility of abovementioned confounding effects.
When analyzing the impact of osteocalcin on the incidence of fractures in the evaluated group of children, one needs to remember that the substantial age-related and growth-related variability of biochemical tests may mask the genetic effect [20] .
Biochemical abnormalities and reduced bone mass may be independent risk factors for bone fractures and may depend on genetic factors, because the bone turnover rate and bone mineral density both have a strong genetic background [7, 19, 20] .
The impact of genetic determinants of bone tissue was evaluated in children and adolescents, because the optimal genetic effect is evident in children aged up to 20 years [21, 22] . In studies conducted by Baroncelli et al., evaluating the association of VDR variability with bone mass in children in pre-pubertal period, no interactions have been reported between BsmI polymorphism and bone turnover markers (including osteocalcin), or bone mineral density [20] . The study however, did not evaluate the relation of VDR variability with fracture incidence in children, which was the main point of our study. Among children with reduced BMD and fractures, we have noted that VDR ApaI a carriage increased the risk of fractures, while carriage of VDR BsmI b allele of VDR exerted a protective effect.
The correlation between VDR FokI polymorphism and bone mineral density in pubertal children was evaluated earlier by the Abrams et al. His study showed that the FokI FF homozygosity is related to higher BMDt values in patients receiving an excess of 800 mg Ca daily. This indicates that BMD is not solely dependent upon genetic factors, but also upon environmental ones, such as calcium intake [23] . Results of studies on the matter are however somewhat conflicting. Several demonstrate the lack of association between BMD, fractures and genetic variability of VDR [24, 25] .
While others confirm associations between the FokI FF genotype was related to increased bone mass (potential reduction of fracture risk) but Ff heterozygosity was related to the lowest fracture risk as shown in a population of Chinese children aged 6-10 years [26] . A study conducted by van der Sluis et al. showed association BsmI, ApaI and TaqI polymorphisms of VDR with vertebral height and vertebral body width, but not with bone mass in children and young adults [27] .
The relation between the three VDR polymorphisms mentioned above and BMD was also studied by Ferrari et al. Their report suggested a joint effect of FokI (ff), BsmI (bb) and ApaI (aa) homozygosity resulting in reduced BMD within the lumbar section of the spine in prepubertal girls [28] .
Based on our own studies and current literature, it is safe to assume that bone fractures are the final product of a complex interplay of a multitude of genetic and environmental factors. In our study, the focus was on the links between VDR polymorphisms and BMD leading through such a mechanism to increased risk of fractures. Carriage of BsmI b allele reduced the risk of bone fractures in the analysed group, while the ApaI a allele carriage was related to an increased risk of fractures in children with reduced bone mass. Presented results, as any on the subject, should be interpreted with caution, as the study group was of limited numbers and could obviously not evaluate complex behavioural and environmental factors. Moreover, the ethnic identity of the studied population should also be taken into account, as different populations may have drastically different genotype frequencies resulting in discrepant strengths of genetic effect. Previous reports describing a group recruited in the Greater Poland region (Wielkopolska) corroborate with our observations in that matter. HorstSikorska et al., showed a greater frequency of both aa ApaI and bb BsmI genotypes in a group of adult female patients with osteoporotic fractures than in controls [29] . Despite a different clinical setting, the direction and magnitude of the clinical effect of genetic variability at VDR polymorphic loci, her study shows a similar effect to this one, performed on children from Łódź region.
Results
1. Carriage of BsmI b allele reduces, while carriage of ApaI a allele and heightened osteoclacin level increase the risk of fractures in children with reduced bone mass. 2. VDR polymorphism, bone mineral density and bone formation marker -osteocalcin maybe considered as risk factor for fracture in children from Łódź region.
